Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]

The role of the PI3K and TOR pathways in cancer

Dr David Fruman - University of California, Irvine, USA

The role of the PI3K and TOR pathways in cancer ( Dr David Fruman - University of California, Irvine, USA )

Utilising disease heterogeneity and emerging biomarkers to individualise...

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium

Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )

Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following...

Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA

Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following cystectomy for bladder cancer ( Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA )

Atezolizumab for platinum-treated locally advanced or metastatic urothelial...

Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA

Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma ( Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA )

Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets

Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA

Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )

Regular aspirin use may reduce risk of dying from prostate cancer

Dr Christophe Allard - Massachusetts General Hospital, Boston, USA

Regular aspirin use may reduce risk of dying from prostate cancer ( Dr Christophe Allard - Massachusetts General Hospital, Boston, USA )

Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours

Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours ( Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )

Actionable targets in patients with cisplatin-resistant advanced germ cell...

Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA

Actionable targets in patients with cisplatin-resistant advanced germ cell tumours ( Dr Aditya Bagrodia - Memorial Sloan Kettering New York, USA )

Improving cancer control in low-middle income countries and creating a global...

Mrs Ann McMikel - American Cancer Society, Atlanta, USA

Improving cancer control in low-middle income countries and creating a global network of expertise ( Mrs Ann McMikel - American Cancer Society, Atlanta, USA )

ER and FGFR1 interaction critical in endocrine resistant breast cancer

Dr Luigi Formisano - Vanderbilt University Nashville, USA

ER and FGFR1 interaction critical in endocrine resistant breast cancer ( Dr Luigi Formisano - Vanderbilt University Nashville, USA )

Hormonal treatments produce similar quality of life outcomes in DCIS

Prof Patricia Ganz - UCLA, Los Angeles, USA

Hormonal treatments produce similar quality of life outcomes in DCIS ( Prof Patricia Ganz - UCLA, Los Angeles, USA )

No significant difference in recurrence rates among women with DCIS taking...

Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United...

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom )

More from ecancer